Normal and Pathological NRF2 Signalling in the Central Nervous System
Open Access
- 22 July 2022
- journal article
- review article
- Published by MDPI AG in Antioxidants
- Vol. 11 (8) , 1426
Abstract
The nuclear factor erythroid 2-related factor 2 (NRF2) was originally described as a master regulator of antioxidant cellular response, but in the time since, numerous important biological functions linked to cell survival, cellular detoxification, metabolism, autophagy, proteostasis, inflammation, immunity, and differentiation have been attributed to this pleiotropic transcription factor that regulates hundreds of genes. After 40 years of in-depth research and key discoveries, NRF2 is now at the center of a vast regulatory network, revealing NRF2 signalling as increasingly complex. It is widely recognized that reactive oxygen species (ROS) play a key role in human physiological and pathological processes such as ageing, obesity, diabetes, cancer, and neurodegenerative diseases. The high oxygen consumption associated with high levels of free iron and oxidizable unsaturated lipids make the brain particularly vulnerable to oxidative stress. A good stability of NRF2 activity is thus crucial to maintain the redox balance and therefore brain homeostasis. In this review, we have gathered recent data about the contribution of the NRF2 pathway in the healthy brain as well as during metabolic diseases, cancer, ageing, and ageing-related neurodegenerative diseases. We also discuss promising therapeutic strategies and the need for better understanding of cell-type-specific functions of NRF2 in these different fields.Keywords
Funding Information
- Fonds National de Recherche de Luxembourg (FNR)-PRIDE (PRIDE17/12244779/PARK-Q, PEARL P16/BM/11192868)
- FNR, Fondation du Pélican de Mie et Pierre Hippert-Faber, Luxembourg Rotary Foundation, Luxembourg Personalized Medicine Consortium, and University of Luxembourg Internal Research Project (PRIDE17/12244779/PARK-Q, PEARL P16/BM/11192868)
- FNR (PRIDE17/12244779/PARK-Q, PEARL P16/BM/11192868)
This publication has 316 references indexed in Scilit:
- Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathyRedox Biology, 2013
- Enhancer and promoter interactions—long distance callsCurrent Opinion in Genetics & Development, 2012
- Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: Restoring effects of inhibitors of HDACs, p38 MAPK and GSK3βNeurobiology of Disease, 2011
- Development of Neh2-Luciferase Reporter and Its Application for High Throughput Screening and Real-Time Monitoring of Nrf2 ActivatorsChemistry & Biology, 2011
- The sites and topology of mitochondrial superoxide productionExperimental Gerontology, 2010
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- Activation of Nrf2-antioxidant signaling attenuates NFκB-inflammatory response and elicits apoptosisBiochemical Pharmacology, 2008
- Nrf2-mediated protection against 6-hydroxydopamineBrain Research, 2007
- Age-related changes in glutathione and glutathione-related enzymes in rat brainBrain Research, 2006
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003